Hints and tips:
Related Special Reports
...Roche will pay $7.1bn upfront and a near-term milestone payment of $150mn. Pfizer will keep the commercialisation rights outside the US and Japan....
...Consider how Roche spent its cash. It acquired obesity drug developer Carmot Therapeutics for $2.7bn....
...Such software is part of the new and growing sector of “collaborative work management”, where providers include Asana and Monday.com....
...The drugmakers Pfizer and Roche said they are piloting use of rFC at some of their facilities....
...Collin Roche, co-chief executive of GTCR, said in a statement that the firm had “tremendous confidence in the opportunity for sustained, long-term growth at Worldpay”....
...The active ingredient is used in La Roche Posay’s Lipikar Eczema Med cream....
...Roche told the Financial Times it was reviewing its legal and policy options regarding the “negative impacts of IRA on patients and innovation”....
...“If we see something large that is attractive, we can chase it, but we don’t feel pressure to do that,” Roche told DD in an interview....
...Illumina was the fourth-largest spender on lobbying among biotech and pharma companies in 2022 at $9.4mn, behind only Pfizer, Roche and Amgen, which are much larger companies, according to an analysis by...
...Nonetheless, the drug represents a major coup for Eisai, a company dwarfed by rivals such as Roche and Eli Lilly....
...Shares in Eli Lilly and Roche also gained....
...Job moves Former Roche boss Bill Anderson will become the next chief executive of Bayer. His predecessor Werner Baumann has faced pressure from activist investors including Jeff Ubben....
...But he said it would not bury the theory altogether because of forthcoming results from late-stage trials of three drugs from Roche and Eli Lilly....
...Abcam creates products for scientific research, including antibodies and other materials that can be used as drugs or diagnostics, partnering with companies and non-profits such as Roche and Cancer Research...
...Both agencies also represent screenwriters including Georgia Pritchett, who has written for HBO’s Succession, and Tony Roche, whose credits include The Thick of It....
...A decade ago, “pure pharma” companies such as Roche and AstraZeneca were a shrinking minority. Novartis exemplified a trend for diversification. Now, the Swiss giant is shedding non-core businesses....
...Mattia Binotto, team principal of Scuderia Ferrari, which has a firm grip on third place in the constructor’s championship, credits Netflix with attracting new fans....
...There are high expectations of an antiviral pill being developed by Atea Pharmaceuticals, working in partnership with Roche. Molnupiravir, if approved, will eat into rivals’ sales....
...Swiss drugmaker Roche is also currently trialling a treatment for the disease....
...Outside the US, where the medicine is distributed by Roche, there is neither the same polarisation nor as much awareness. But the ultimate problem is not demand but supply....
...Another antiviral developed by Roche and Atea Pharmaceuticals failed to reduce participants’ viral load any more than a placebo when studied in a mixed group of vaccinated and unvaccinated....
...Collin Roche, co-CEO and managing director of GTCR: “good businesses that we can invest into and help them to improve and realise their potential.” Faites vos jeux!...
...Pfizer and Roche are also developing antiviral pills. Trial results are expected before the end of the year. Additional reporting by Peter Wells in New York...
...Drugs from rival pharma groups Eli Lilly and Roche may also enter the market earlier than expected....
...In February 2020 the CMA looked at Swiss group Roche’s planned $5bn acquisition of US company Spark despite the fact the latter had no UK turnover....
International Edition